Stratifying risk in acute myeloid leukemia, daratumumab plus chemotherapy in relapsed-refractory pediatric leukemias, and a method for creating genetically engineered platelets
This episode covers a new risk classification for acute myeloid leukemia, the efficacy of daratumumab plus chemotherapy in pediatric leukemias, and a method for creating genetically engineered platelets compatible with blood banking practices.